CD274 and Hyperglycemia: Hyperglycemia-driven suppression of the PD-1/PD-L1 and CTLA-4 pathways leads to persistent T cell activation, regulatory T cell failure, and endothelial barrier instability, creating an ideal environment for vascular inflammation and plaque progression.